Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma are highly dependent on oxidative phosphorylation

Katrin Birkenmeier1, Stefan Dröse2,3, Ilka Wittig3

  • 1Dr. Senckenberg Institute of Pathology, Goethe-University Hospital, Theodor-Stern-Kai 7, Frankfurt Am Main, 60596, Germany.

Insights

Hodgkin-Reed-Sternberg cells in classical Hodgkin's lymphoma rely heavily on oxidative phosphorylation for energy. Targeting this metabolic pathway presents a potential new therapeutic strategy for classical Hodgkin's lymphoma.

Area of Science:

  • Cellular Metabolism
  • Oncology
  • Immunology

Background:

  • Germinal center (GC) B cells are the origin of several lymphomas, including classical Hodgkin's lymphoma (cHL).
  • Understanding the unique metabolic properties of tumor cells is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To compare the metabolic characteristics of Hodgkin-Reed-Sternberg (HRS) cells (cHL tumor cells) with normal GC B cells.
  • To investigate the role of oxidative phosphorylation (OXPHOS) in HRS cell growth and viability.

Main Methods:

  • Comparative analysis of metabolic profiles between HRS cells and GC B cells.
  • Assessment of mitochondrial mass, protein expression related to oxidative metabolism, and mitochondrial biogenesis markers.
  • Investigation of the role of NFkappaB in metabolic shifts.
  • Functional assays to determine the dependence of HRS cells on OXPHOS for growth and viability.

Main Results:

  • HRS cells exhibit a significant shift towards oxidative phosphorylation (OXPHOS)-linked ATP synthesis compared to GC B cells.
  • Mitochondrial mass and key proteins involved in oxidative metabolism and biogenesis are upregulated in cHL.
  • NFkappaB signaling promotes the shift to OXPHOS in HRS cells.
  • HRS cell growth and viability are critically dependent on OXPHOS, with minimal lactate production observed.

Conclusions:

  • Oxidative phosphorylation is the dominant energy production pathway in HRS cells, with nonoxidative ATP production playing a minor role.
  • The reliance of HRS cells on OXPHOS suggests it as a potential novel therapeutic target for cHL.
  • Targeting OXPHOS may offer new avenues for treatment strategies in classical Hodgkin's lymphoma.